| | 
Part, Chapter, Paragraph
1 II, 5. 2. 4 | hypertension prevalence ( 160 o 95 mmHg; 140 o 90 mmHg;
2 II, 5. 2. 4 | 95 mmHg; 140 o 90 mmHg; 160 mmHg).~Table 5.2.8 shows
3 II, 5. 2. 6 | very high risk patients to 160 mg/dL in very low risk subjects)
4 II, 5. 3. 5 | 151)~In 2006 Europe saw, 160,000 new cases and 118,000
5 II, 5. 5. 3 | NC/EC~Prevalent cohort~160~67.8~2.4~Alstrom, 1950 (*)~ ~
6 II, 5. 5. 3 | Czech Republic, with rates up to 160 in three small northern
7 II, 5. 7. 3 | incidence rates in Canada (160 pmp in 2005) are similar
8 II, 5. 8. 4 | bronchitis from smoking by 160%. Neither a steeper decline
9 II, 5. 15. 3 | gene(s) is identified and 2,160 for which it remains still
10 II, 9. 3. 2 | Europe, between 140 and 160 per 100 000 in the 1980s.
11 III, 10. 2. 2 | very high risk patients to 160 mg/dL in very low risk subjects)
12 III, 10. 4. 2(41)| of the European Union l 160/98~
13 III, 10. 4. 3 | 1976): Council Directive 76/160/EC of 8 December 1975 concerning
14 III, 10. 4. 3 | 2006 repealing Directive 76/160/EEC. htt ML~European Commission (
15 III, 10. 4. 5 | the old one (Directive 76/160/EEC) by the end of 2014
16 III, 10. 4. 5 | the old one (Directive 76/160/EEC) (European Commission,
17 III, 10. 4. 5 | 2006 repealing Directive 76/160/EEC. htt ML~European Commission (
18 IV, 12. 10 | and repealing Directive 76/160/EEC – being transpose.~ -
19 IV, 12. 10 | according to the directive 76/160/EEC~national plans on environmental
|
|
| |
